44 results on '"Zheng, Qiufan"'
Search Results
2. Construction of immune score and its prognostic value in invasive lobular carcinoma of the breast using computational pathology analysis
3. Pyrotinib Combined with Vinorelbine in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer: A Multicenter, Single-arm, Prospective Study
4. Genetic analysis of oligo-recurrence breast cancer: correlation with clinical outcomes
5. What is the appropriate genetic testing criteria for breast cancer in the Chinese population?—Analysis of genetic and clinical features from a single cancer center database
6. Construction of immune score and its prognostic value in invasive lobular carcinoma of the breast using computational pathology analysis
7. Current Situation of Diagnosis and Treatment of HER2-Positive Metastatic Breast Cancer Patients in China: A Nationwide Cross-Sectional Survey of Doctors
8. Construction and validation of a macrophage-related prognostic index to predict the overall survival in patients with early-stage triple-negative breast cancer
9. Long-term survival after sentinel lymph node biopsy or axillary lymph node dissection in pN0 breast cancer patients: a population-based study
10. Systemic Therapy Combined with Locoregional Therapy Improved Survival in Oligometastatic Breast Cancer: A Single-Center Retrospective Cohort Study
11. Nail pigmentation induced by chemotherapy: an observational study of patients with early-stage breast cancer
12. Germline Mutational Profiles and Clinicopathological Features Of Hereditary Breast Cancer In Chinese Population
13. Distribution Characteristics and Prognostic Value of Immune Infiltration in Oligometastatic Breast Cancer
14. CPSF4 promotes triple negative breast cancer metastasis by upregulating MDM4
15. The Prognostic Value of Skin Involvement in Breast Cancer Patients With Chest Wall Recurrence
16. Clinical Genomic Profiling to Identify Actionable Alterations for Very Early Relapsed Triple-Negative Breast Cancer Patients in the Chinese Population
17. Genetic Analysis of Oligo-Metastatic Breast Cancer: Correlation with Clinicopathological Features
18. Clinical genomic profiling to identify actionable alterations for very early relapsed triple-negative breast cancer patients in the Chinese population
19. A Phase II Study of Fulvestrant 500 mg as Maintenance Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Patients with Advanced Breast Cancer After First-Line Chemotherapy
20. Identification and characterization of critical genes associated with tamoxifen resistance in breast cancer
21. A Single-Cell Immune Atlas of Triple Negative Breast Cancer Reveals Novel Immune Cell Subsets
22. Identification of a Novel KIF5B-RET, ABHD17C-RET Double-Fusion Variant in Lung Adenocarcinoma and Response to Cabozantinib
23. EGFR mutation genotypes affect efficacy and resistance mechanisms of osimertinib in T790M-positive NSCLC patients
24. Efficacy and safety of pegfilgrastim in prophylaxis of chemotherapy-induced neutropenia in breast cancer patients.
25. Metronomic chemotherapy of cyclophosphamide plus methotrexate for advanced breast cancer: Real‐world data analyses and experience of one center
26. Cover Image: Metronomic chemotherapy of cyclophosphamide plus methotrexate for advanced breast cancer: Real‐world data analyses and experience of one center
27. Emergence of EGFR G724S After Progression on Osimertinib Responded to Afatinib Monotherapy
28. Administration of Lapatinib with Food Increases Its Plasma Concentration in Chinese Patients with Metastatic Breast Cancer: A Prospective Phase II Study
29. Local treatment for liver oligometastases in breast cancer patients: identification of prognostic factors and exploration of appropriate treatment strategy
30. EGFR T790M relative mutation purity predicts osimertinib treatment efficacy in non‐small cell lung cancer patients
31. The genomic landscape of Epstein-Barr virus-associated pulmonary lymphoepithelioma-like carcinoma
32. A Single-Cell Immune Atlas of Triple Negative Breast Cancer Reveals Novel Immune Cell Subsets
33. The correlations of tumor mutational burden among single-region tissue, multi-region tissues and blood in non-small cell lung cancer
34. CDK4/6 inhibitor palbociclib enhances the effect of pyrotinib in HER2-positive breast cancer
35. Intratumor heterogeneity comparison among different subtypes of non-small-cell lung cancer through multi-region tissue and matched ctDNA sequencing
36. Clinical value of circulating ESR1 mutations for patients with metastatic breast cancer: a meta-analysis
37. Clinical implication of platelet-lymphocyte ratio and PD-L1 in breast cancer patients
38. The prognostic significance of topoisomerase II alpha protein in early stage luminal breast cancer
39. Fulvestrant as maintenance therapy after first-line chemotherapy in patients with hormone receptor-positive, HER2-negative advanced breast cancer (FANCY), a prospective, multicenter, single arm phase 2 study.
40. Prognostic value of endocrine treatment-related symptoms in patients with breast cancer: a meta-analysis
41. Endocrine treatment-related symptoms and outcomes in breast cancer: A systematic review and meta-analysis.
42. Fulvestrant as maintenance therapy after first-line chemotherapy in postmenopausal hormone receptor-positive, HER2-negative advanced breast cancer patients (FANCY): A prospective, multicenter, single arm phase II study.
43. Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway
44. Selective Estrogen Receptor Modulator-Associated Nonalcoholic Fatty Liver Disease Improved Survival in Patients With Breast Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.